Articles / Study suggests possible link between artificial sweeteners and heart disease
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
Artificial sweeteners are present in thousands of food and beverage brands worldwide, however they remain a controversial topic and are currently being re-evaluated by the European Food Safety Authority, the World Health Organization, and other health agencies.
A team of researchers from the French National Institute for Health and Medical Research (Inserm) and colleagues conducted the large scale prospective cohort study with findings suggesting a potential direct association between higher artificial sweetener consumption (especially aspartame, acesulfame potassium, and sucralose) and increased cardiovascular disease risk.
More information: Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort, The BMJ (2022). DOI: 10.1136/bmj-2022-071204
Journal information: British Medical Journal (BMJ)
MHT For Women With History or Risk of Cancer
Muscle Health in the Elderly
GLP-1s For OSA
Oral Corticosteroid Stewardship For Asthma – Why it is Important
Strongly agree
Somewhat agree
Neutral
Somewhat disagree
strongly disagree
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease